| Literature DB >> 36105775 |
Seong-Joon Lee1, Jin Soo Lee1, Min Kim1, So Young Park1, Ji Hyun Park2, Bumhee Park2,3, Woo Sang Jung4, Jin Wook Choi4, Ji Man Hong1.
Abstract
Background: The mechanical and physiological properties of the arterial wall might affect the behavior of spontaneous cervicocephalic arterial dissections (CCAD). We aimed to determine the effects of endothelial function and arterial stiffness on the clinical characteristics and outcomes of CCAD using brachial flow-mediated dilation (FMD) and brachial-ankle pulse wave velocity (PWV).Entities:
Keywords: arterial stiffness; cervicocephalic arterial dissection; endothelial function; flowmediated dilatation; pulse wave velocity
Year: 2022 PMID: 36105775 PMCID: PMC9464973 DOI: 10.3389/fneur.2022.968488
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1Flowchart of patient inclusion for the current study. CCAD, cervicocephalic artery dissection; SAH, subarachnoid hemorrhage; ER, emergency room; FMD, flow-mediated dilation; PWV, pulse wave velocity.
Figure 2Examples of spontaneous arterial healing and aneurysmal changes. (A) An originally stenotic dissection segment shows arterial healing with improved stenosis degree. (B) A dissection segment with dilatation pattern (dilatation & stenosis) shows arterial healing with reduced aneurysm size and improved stenosis. (C) An initially dilated dissection segment shows aneurysmal enlargement on serial imaging.
Baseline profiles, treatment, clinical, and imaging characteristics according to dichotomized state of flow mediated dilatation.
|
| |||
|---|---|---|---|
| Age | 51 ± 11 | 45 ± 10 | 0.002 |
| Sex, male | 46 (86.8%) | 67 (72.0%) | 0.040 |
| Onset to presentation, d | 1 [0–3.5] | 1 [0–5.5] | 0.489 |
| Presentation pattern | 0.340 | ||
| Ischemic stroke | 43 (81.1%) | 69 (74.2%) | |
| Headache, others | 10 (18.9%) | 24 (25.8%) | |
| Onset to FMD, d | 9 [6–13] | 10 [6–14] | 0.860 |
| Morphology | 0.368 | ||
| Stenosis | 17 (32.1%) | 20 (21.5%) | |
| Dilatation | 16 (30.2%) | 32 (34.4%) | |
| Occlusion | 20 (37.7%) | 41 (44.1%) | |
| Circulation | 0.992 | ||
| Carotid | 16 (30.2%) | 28 (30.1%) | |
| Vertebro-basilar | 37 (69.8%) | 65 (69.9%) | |
| Intra vs. extracranial | 0.002 | ||
| Intracranial | 43 (81.1%) | 52 (55.9%) | |
| Extracranial | 10 (18.9%) | 41 (44.1%) | |
| HTN | 28 (52.8%) | 30 (32.3%) | 0.015 |
| DM | 5 (9.4%) | 7 (7.5%) | 0.687 |
| Smoking | 25 (47.2%) | 35 (37.6%) | 0.260 |
| Dyslipidemia | 13 (24.5%) | 20 (21.5%) | 0.675 |
| Treatments | 0.398 | ||
| Medical | 47 (88.7%) | 81 (87.1%) | |
| Acute intervention | 5 (9.4%) | 10 (10.8%) | |
| Delayed intervention | 1 (1.9%) | 0 (0.0%) | |
| Bypass operation | 0 (0.0%) | 2 (2.2%) | |
| Medications | 0.003 | ||
| None | 5 (9.4%) | 3 (3.2%) | |
| Antiplatelet | 26 (49.1%) | 25 (26.9%) | |
| Anticoagulation | 22 (41.5%) | 65 (69.9%) | |
|
| ( | ( | |
| 3-month mRS | 1.0 [1.0–2.0] | 1.0 [0.0–1.0] | 0.068 |
| New ischemic stroke | 5 (9.4%) | 3 (3.3%) | 0.125 |
| New SAH | 0 (0.0%) | 0 (0.0%) | |
|
| ( | ( | |
| Spont. arterial healing | 15 (31.3%) | 57 (70.4%) | <0.001 |
| Aneurysm enlargement | 3 (6.3%) | 1 (1.2%) | 0.112 |
|
| ( | ( | |
| NIHSS | 3.0 [1.0–5.0] | 2.0 [1.0–5.0] | 0.875 |
| END | 7 (16.3%) | 6 (8.7%) | 0.223 |
| 3-month mRS | 1.0 [1.0–2.0] | 1.0 [0.0–2.0] | 0.308 |
FMD, flow mediated dilatation; HTN, hypertension; DM, diabetes mellitus; mRS, modified Rankin Scale; SAH, subarachnoid hemorrhage; NIHSS, National Institute of Health Stroke Scale; END, early neurological deterioration.
Multivariable analysis to determine the association between flow mediated dilatation values and spontaneous arterial healing.
|
|
|
|
|---|---|---|
|
| ||
| Normal FMD (vs. decreased) | 4.52 [1.95–10.52] | <0.001 |
| Age | 0.98 [0.94–1.02] | 0.347 |
| DM | 0.07 [0.01–0.70] | 0.023 |
| Morphology | ||
| Stenosis | Reference | |
| Dilatation | 1.71 [0.60–4.93] | 0.318 |
| Occlusion | 1.42 [0.49–4.10] | 0.516 |
| Extracranial (vs. intracranial) | 1.51 [0.57–4.00] | 0.411 |
|
| ||
| FMD as a continuous variable | 1.37 [1.06–1.756] | 0.014 |
| Age | 0.98 [0.94–1.02] | 0.278 |
| DM | 0.06 [0.01–0.64] | 0.02 |
| Morphology | ||
| Stenosis | Reference | |
| Dilatation | 1.94 [0.69–5.47] | 0.21 |
| Occlusion | 1.58 [0.55–4.48] | 0.394 |
| Extracranial (vs. intracranial) | 1.45 [0.55–3.81] | 0.457 |
FMD, flow mediated dilatation; DM, diabetes mellitus.
Baseline profiles, treatment, clinical, and imaging characteristics according to the tertiles of pulse wave velocity values.
|
|
|
|
| |
|---|---|---|---|---|
| Age | 40 ± 10 | 47 ± 8 | 54 ± 10 | <0.001* |
| Sex, male | 36 (73.5%) | 37 (74.0%) | 40 (85.1%) | 0.307 |
| Onset to presentation, d | 2 [0–6.5] | 1.5 [0–6] | 1 [0–2] | 0.007† |
| Presentation pattern | 0.001 | |||
| Ischemic stroke | 32 (65.3%) | 35 (70.0%) | 45 (95.7%) | |
| Headache, others | 17 (34.7%) | 15 (30.0%) | 2 (4.3%) | |
| Onset to PWV | 11 [6–18] | 10 [6–16] | 8 [5–12] | 0.198 |
| Morphology | 0.037 | |||
| Stenosis | 14 (28.6%) | 11 (22.0%) | 12 (25.5%) | |
| Dilatation | 23 (46.9%) | 13 (26.0%) | 12 (25.5%) | |
| Occlusion | 12 (24.5%) | 26 (52.0%) | 23 (48.9%) | |
| Circulation | 0.879 | |||
| Carotid | 16 (32.7%) | 14 (28.0%) | 14 (29.8%) | |
| Vertebro-basilar | 33 (67.3%) | 36 (72.0%) | 33 (70.2%) | |
| Intra vs. extracranial | 0.809 | |||
| Intracranial | 32 (65.3%) | 34 (68.0%) | 29 (61.7%) | |
| Extracranial | 17 (34.7%) | 16 (32.0%) | 18 (38.3%) | |
| HTN | 10 (20.4%) | 19 (38.0%) | 29 (61.7%) | <0.001 |
| DM | 3 (6.1%) | 3 (6.0%) | 6 (12.8%) | 0.387 |
| Smoking | 18 (36.7%) | 22 (44.0%) | 20 (42.6%) | 0.741 |
| Dyslipidemia | 7 (14.3%) | 13 (26.0%) | 13 (27.7%) | 0.228 |
| Treatments | 0.762 | |||
| Medical | 42 (85.7%) | 44 (88.0%) | 42 (89.4%) | |
| Acute intervention | 6 (12.2%) | 5 (10.0%) | 4 (8.5%) | |
| Delayed intervention | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) | |
| Bypass operation | 0 (0.0%) | 1 (2.0%) | 1 (2.1%) | |
| Medications | 0.323 | |||
| None | 3 (6.1%) | 4 (8.0%) | 1 (2.1%) | |
| Antiplatelet | 17 (34.7%) | 13 (26.0%) | 21 (44.7%) | |
| Anticoagulation | 29 (59.2%) | 33 (66.0%) | 25 (53.2%) | |
|
| ( | ( | ( | |
| 3-month mRS | 1.0 [0.0–1.0] | 1.0 [0.25–2.0] | 1.0 [0.0–2.0] | 0.055 |
| New ischemic stroke | 1 (2.1%) | 0 (0.0%) | 7 (14.9%) | 0.003 |
| New SAH | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
|
| ( | ( | ( | |
| Spont. arterial healing | 25 (56.8%) | 28 (63.6%) | 19 (46.3%) | 0.272 |
| Aneurysm enlargement | 4 (9.1%) | 0 (0.0%) | 0 (0.0%) | 0.019 |
|
| ( | ( | ( | |
| NIHSS | 2.0 [1.0–4.0] | 3.0 [1.0–5.0] | 3.0 [1.0–5.0] | 0.889 |
| END | 3 (9.4%) | 4 (11.4%) | 6 (13.3%) | 0.866 |
| 3-month mRS | 1.0 [0.0–1.0] | 1.0 [1.0–2.0] | 1.0 [0.0–2.0] | 0.084 |
HTN, hypertension; DM, diabetes mellitus; mRS, modified Rankin Scale; SAH, subarachnoid hemorrhage; NIHSS, National Institute of Health Stroke Scale; END, early neurological deterioration.
*Post hoc Bonferroni test, p < 0.005 for all inter-group comparisons.
†Post hoc Bonferroni test, 1st tertile vs. 3rd tertile, p = 0.005.
Multivariable analysis to evaluate the association between pulse wave velocity values and ischemic stroke presentation.
|
|
|
|
|---|---|---|
|
| ||
| PWV tertile | ||
| 1st tertile | Reference | |
| 2nd tertile | 1.37 [0.46–4.04] | 0.568 |
| 3rd tertile | 17.05 [3.07–94.82] | 0.001 |
| Age | 0.97 [0.92–1.02] | 0.202 |
| Sex, male | 2.28 [0.85–6.07] | 0.102 |
| Morphology | ||
| Stenosis | Reference | |
| Dilatation | 0.41 [0.14–1.22] | 0.108 |
| Occlusion | 1.56 [0.43–5.68] | 0.501 |
| Extracranial (vs. intracranial) | 4.45 [1.25–15.89] | 0.021 |
|
| ||
| PWV/100, continuous variable | 1.44 [1.14–1.82] | 0.002 |
| Age | 0.96 [0.91–1.01] | 0.106 |
| Sex, male | 2.17 [0.82–5.75] | 0.119 |
| Morphology | ||
| Stenosis | Reference | |
| Dilatation | 0.41 [0.14–1.21] | 0.106 |
| Occlusion | 1.42 [0.40–4.97] | 0.586 |
| Extracranial (vs. intracranial) | 4.79 [1.34–17.1] | 0.016 |
PWV, pulse wave velocity.